The Seniors Deserve SMARTER Care Act of 2025 prohibits the Secretary of Health and Human Services from implementing the WISeR model described in the Federal Register notice titled “Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model” (90 Fed. Reg. 28749 (July 1, 2025)), and from implementing any substantially similar model.
The bill is targeted: it does not amend Medicare’s underlying statutes or broadly ban prior authorization, but it creates a statutory bar against deploying that specific demonstration or anything that is substantially the same.
Why this matters: WISeR, by title, would test prior-authorization controls for services that CMS considers wasteful or inappropriate. Blocking the model removes a narrowly defined tool for testing utilization management in Medicare, with immediate implications for CMS’s ability to pilot payment and service-delivery interventions intended to reduce unnecessary care.
That affects providers, beneficiaries, and agencies planning operational or contract changes tied to the model’s deployment.
At a Glance
What It Does
The bill directs that the Secretary of HHS may not implement the WISeR model as described in the cited Federal Register notice, nor any model that is substantially similar. It is a statutory prohibition aimed at a specific CMS demonstration (or substantially similar variants).
Who It Affects
The prohibition reaches CMS and the Secretary’s authority to deploy the WISeR demonstration under the Medicare program; operationally it would affect contractors, providers who would have been subject to prior authorization under the model, and Medicare beneficiaries whose services might have been targeted.
Why It Matters
The measure forecloses a defined pathway for CMS to test prior-authorization as a lever to reduce wasteful or inappropriate Medicare services, shifting the balance between experimentation for cost-control and protecting access and administrative simplicity for providers and patients.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill contains two operative elements: a short title and a single substantive prohibition. The prohibition is narrow in form — it names the WISeR model by referencing the Federal Register notice and then bars implementation of that model or “any substantially similar model.” That language is crafted to prevent CMS from running the specific demonstration announced in the notice and to capture close variants that would follow the same design or policy goals.
Because the statute points to a Federal Register notice rather than recodifying policy details, the prohibition’s practical scope will turn on how courts or agencies interpret “substantially similar.” The bill does not define that term, nor does it change other statutory authorities that allow CMS or the Center for Medicare & Medicaid Innovation (CMMI) to test alternative payment models. In consequence, the prohibition is targeted: it removes a concrete, named experiment from CMS’s toolkit without expressly altering CMS’s broader authority to pursue other demonstrations or policy changes.Operationally, the ban impacts administrative planning and contracts tied to the WISeR effort.
If enacted, the Secretary could not proceed with the particular prior-authorization rollout described in the notice; CMS would need to abandon or redesign workstreams, pause contractor procurements or operational readiness activities tied to WISeR, and reassess any guidance or outreach that assumed the demonstration would move forward. The bill does not create an enforcement mechanism beyond the statutory bar on the Secretary, nor does it provide replacement policy measures to address the waste or inappropriate-use concerns the WISeR model intended to target.Finally, the bill leaves open several adjacent pathways.
It does not expressly prohibit HHS from pursuing other forms of utilization management or from testing alternative models with different mechanics. The practical effect will depend on how narrowly HHS can redesign a demonstration to achieve similar objectives while avoiding the “substantially similar” threshold the statute imposes.
The Five Things You Need to Know
The bill forbids the Secretary of HHS from implementing the WISeR model as described in 90 Fed. Reg. 28749 (July 1, 2025).
It also bars implementation of “any substantially similar model,” a phrase that broadens the prohibition beyond the single notice but is left undefined.
The statutory ban applies to implementation under the Medicare program; the text does not amend underlying Medicare statute or rescind other CMS authorities.
There is no explicit enforcement mechanism, private right of action, or penalty language in the bill—its operative effect is to remove CMS’s authority to implement the named model.
By singling out a Federal Register notice rather than codifying technical details, the bill makes legal scope hinge on interpretation of what counts as the notice’s model and what qualifies as substantially similar.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the Act two short titles: the Seniors Deserve Streamlined Medical Approvals for Timely, Efficient Recovery Care Act of 2025 and the Seniors Deserve SMARTER Care Act of 2025. This is housekeeping but signals the bill’s policy framing around streamlining approvals and opposing the specific WISeR prior-authorization approach.
Prohibition on implementing the WISeR model
Directs that the Secretary of HHS may not implement the innovative payment and service delivery model described in the Federal Register notice referenced in the text. Practically, this prevents CMS from proceeding with the named demonstration in its published form, stopping activities that would operationalize the exact model described in that notice.
Prohibition extends to substantially similar models
Adds a catch-all that bars implementation of any model the agency deems substantially similar to WISeR. Because the bill does not define “substantially similar,” this clause is the key legal battleground: it can be interpreted broadly to block near-variants of the WISeR approach or narrowly to cover only close copies. That ambiguity raises questions for CMS about how to design alternative pilots without triggering the statutory ban.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare beneficiaries for services targeted by WISeR — they would avoid additional prior-authorization steps the model would have introduced, reducing potential administrative delays for care.
- Small and rural providers and post-acute-care suppliers that lack large prior-authorization infrastructures — the bill spares them the operational cost and staffing burden of complying with a new, Medicare-specific prior-authorization demonstration.
- Provider trade associations and advocacy groups that opposed WISeR — they gain relief from a demonstration they argued would increase paperwork and disrupt clinical workflows.
Who Bears the Cost
- CMS and the agencies or contractors that invested planning resources in WISeR — they would need to halt implementation activities and potentially absorb sunk costs from design, outreach, and procurement.
- The Medicare program (and taxpayers) if WISeR would have achieved measurable reductions in wasteful or inappropriate services — the statute removes a narrowly scoped tool that might have lowered spending, shifting the fiscal consequence back onto the program.
- Policymakers and analysts seeking evidence on prior-authorization as a cost-control lever — researchers lose an experimental data source that could have informed national policy decisions on utilization management.
Key Issues
The Core Tension
The central dilemma is between two legitimate goals: protecting patients and smaller providers from new prior-authorization burdens that can delay care, versus preserving CMS’s ability to experiment with utilization-management tools that might reduce wasteful spending and improve program integrity; the bill resolves that tension by forbidding one specific experiment, but without settling whether banning experimentation is preferable to testing and measuring trade-offs.
The bill’s operative breadth depends on interpreting “substantially similar.” Because the statute references a Federal Register notice rather than enumerating technical design elements, an HHS lawyer could argue that models with materially different mechanics avoid the ban, while opponents could argue that models with the same purpose and similar effects fall within it. That ambiguity creates compliance risk: CMS must balance the desire to pursue related policy goals against the risk of triggering the statutory prohibition or litigation.
Another tension lies between targeted statutory intervention and broader administrative authority. The bill blocks a named experiment without amending CMS’s general authority to regulate or pilot programs under the Social Security Act and related delegations.
That creates an implementation puzzle: CMS may be able to pursue similar aims using different statutory vehicles or through Medicare Advantage pathways not captured by the WISeR description. The statute’s narrowness thus may catalyze alternative approaches rather than ending the underlying policy debate about prior authorization and utilization management.
Finally, because the bill does not include procedural remedies, funding offsets, or a mechanism for measuring what the demonstration would have achieved, it replaces a testable pilot with an absence of additional policy guidance. Stakeholders on both sides lose the clarity that a carefully designed demonstration could provide — opponents avoid immediate administrative change, but proponents lose an evidence-building opportunity to prove whether prior-authorization for particular services would yield net savings without harming access.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.